Meirav Kedmi

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Ana Alarcón Tomás, Joshua Fein, Shalev Fried et al. · Leukemia · 2022 · 102 citations · Full text

Medicine, Hematology, Oncology +13

The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma

Abraham Avigdor, Tsvi Sirotkin, Meirav Kedmi et al. · Annals of Hematology · 2014 · 58 citations

Medicine, Oncology, Radiology +11

An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma

Sandeep Raj, Teng Fei, Shalev Fried et al. · Nature Medicine · 2025 · 43 citations · Full text

Medicine, Immunology, Oncology +17

Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma

Meirav Kedmi, Roni Shouval, Shalev Fried et al. · Transplantation and Cellular Therapy · 2022 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17

FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes

Tima Davidson, Meirav Kedmi, Abraham Avigdor et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 33 citations

Medicine, Oncology, Radiology +17